CUTISS's Seed Round

CUTISS raised a round of funding on August 30, 2017. Investors include University of Zurich.

CUTISS developed the denovoSkin, a personalized bioengineered skin graft product for the treatment of a broad spectrum of skin defects.…

Articles about CUTISS's Seed Round: